Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Case report

Antineoplastics/folinic-acid

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Aung KL, et al. A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (MOBILITY-002 Trial, NCT02428270). Journal of Clinical Oncology 36 (Suppl.): No. 4, Feb 2018. Available from: URL: https://dx.doi.org/10.1200/JCO.2018.36.4-suppl.409 [abstract] Aung KL, et al. A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (MOBILITY-002 Trial, NCT02428270). Journal of Clinical Oncology 36 (Suppl.): No. 4, Feb 2018. Available from: URL: https://​dx.​doi.​org/​10.​1200/​JCO.​2018.​36.​4-suppl.​409 [abstract]
Metadata
Title
Antineoplastics/folinic-acid
Lack of efficacy
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57193-7

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

COVID-19-vaccine

Case report

Alcohol

Case report

Alcohol